Skip to main content
. 2020 Nov 20;47(1):3–22. doi: 10.3892/ijmm.2020.4794

Figure 14.

Figure 14

Schematic overview of the mechanisms of anti-thrombotic agents used for the treatment of SARS-CoV-2 infection. Anti-thrombotic agents include: i) Anti-coagulants: Unfractionated heparin, Enoxaparin, Danaparoid and warfarin; ii) anti-platelet agents: Aspirin and Dipyridamole; and iii) Fibrinolytic (Thrombolytic) agents: Urokinase, Streptokinase and tPA. tPA, tissue-type plasminogen activator.